These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34146181)

  • 1. Lipoprotein (a): Recent Updates on a Unique Lipoprotein.
    Saeed A; Kinoush S; Virani SS
    Curr Atheroscler Rep; 2021 Jun; 23(8):41. PubMed ID: 34146181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein.
    Saeed A; Virani SS
    Front Biosci (Landmark Ed); 2018 Jan; 23(6):1099-1112. PubMed ID: 28930591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives.
    Vinci P; Di Girolamo FG; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Altamura N; Pirulli A; Zaccari M; Biasinutto C; Roni C; Fiotti N; Schincariol P; Mangogna A; Biolo G
    Int J Environ Res Public Health; 2023 Sep; 20(18):. PubMed ID: 37754581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis.
    Yeang C; Cotter B; Tsimikas S
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):75-85. PubMed ID: 26780907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies.
    Alhomoud IS; Talasaz A; Mehta A; Kelly MS; Sisson EM; Bucheit JD; Brown R; Dixon DL
    Pharmacotherapy; 2023 Oct; 43(10):1051-1063. PubMed ID: 37464942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia.
    Vuorio A; Watts GF; Kovanen PT
    Atherosclerosis; 2019 Feb; 281():25-30. PubMed ID: 30616181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review.
    Duarte Lau F; Giugliano RP
    JAMA Cardiol; 2022 Jul; 7(7):760-769. PubMed ID: 35583875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.
    Scipione CA; Koschinsky ML; Boffa MB
    Crit Rev Clin Lab Sci; 2018 Jan; 55(1):33-54. PubMed ID: 29262744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) and cardiovascular disease.
    Boffa MB; Koschinsky ML
    Biochem J; 2024 Oct; 481(19):1277-1296. PubMed ID: 39302109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
    Naito R; Daida H; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Koga N; Oikawa S; Yamashita S
    J Atheroscler Thromb; 2022 Aug; 29(8):1188-1200. PubMed ID: 34456199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Lp(a): Guidance for Identifying and Managing Patients.
    Hilleman DE; Vacek JL; Backes JM
    South Med J; 2024 Apr; 117(4):208-213. PubMed ID: 38569611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DIAGNOSIS AND TREATMENT OF ELEVATED LIPOPROTEIN(A) IN ISRAEL: CONSENSUS STATEMENT FROM THE ISRAEL SOCIETY FOR RESEARCH, PREVENTION AND TREATMENT OF ATHEROSCLEROSIS AND ISRAEL SOCIETY FOR CLINICAL LABORATORY SCIENCES].
    Zafrir B; Durst R; Henig C; Henkin Y; Itzhakov E; Kaplan M; Gavish D
    Harefuah; 2024 Mar; 163(3):185-190. PubMed ID: 38506362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) in clinical practice: A guide for the clinician.
    Krittanawong C; Maitra NS; El-Sherbini AH; Shah N; Lavie CJ; Shapiro MD; Virani SS
    Prog Cardiovasc Dis; 2023; 79():28-36. PubMed ID: 37516261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities.
    Vuorio A; Watts GF; Schneider WJ; Tsimikas S; Kovanen PT
    J Intern Med; 2020 Jan; 287(1):2-18. PubMed ID: 31858669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a)-60 Years Later-What Do We Know?
    Pasławska A; Tomasik PJ
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology.
    Koschinsky ML; Boffa MB
    Atherosclerosis; 2022 May; 349():92-100. PubMed ID: 35606081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study.
    Obisesan OH; Kou M; Wang FM; Boakye E; Honda Y; Uddin SMI; Dzaye O; Osei AD; Orimoloye OA; Howard-Claudio CM; Coresh J; Blumenthal RS; Hoogeveen RC; Budoff MJ; Matsushita K; Ballantyne CM; Blaha MJ
    J Am Heart Assoc; 2022 Jun; 11(11):e024870. PubMed ID: 35656990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) and atherosclerosis.
    Scanu AM; Lawn RM; Berg K
    Ann Intern Med; 1991 Aug; 115(3):209-18. PubMed ID: 1829339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a), cardiovascular disease, and contemporary management.
    Jacobson TA
    Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Reyes-Soffer G; Ginsberg HN; Berglund L; Duell PB; Heffron SP; Kamstrup PR; Lloyd-Jones DM; Marcovina SM; Yeang C; Koschinsky ML;
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e48-e60. PubMed ID: 34647487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.